Peroxisome proliferators-activated alpha agonist treatment ameliorates hepatic damage in rats with obstructive jaundice: An experimental study

BMC Gastroenterology

Volumn 7, Issue , 2007, Pages

  Cindoruk, Mehmet ^a   Kerem, Mustafa ^a   Karakan, Tarkan ^a   Salman, Bulent ^a   Akin, Okan ^b   Alper, Murat ^b   Erdem, Ozlem ^a   Ünal, Selahattin ^a  

^a GAZI UNIVERSITY FACULTY OF MEDICINE   (Turkey)

^b Kecioren Training and Research Hospital ^*  (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; BILE ACID; BILIRUBIN; FENOFIBRATE; GAMMA GLUTAMYLTRANSFERASE; GUM ARABIC; INTERLEUKIN 1BETA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA AGONIST; TUMOR NECROSIS FACTOR ALPHA; AUTACOID; CYTOKINE; MALONALDEHYDE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALKALINE PHOSPHATASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BILE ACID BLOOD LEVEL; BILIRUBIN BLOOD LEVEL; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG RESPONSE; EXPERIMENTAL STUDY; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; HEPATITIS; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; LIVER INJURY; LIVER NECROSIS; MALE; NONHUMAN; OBSTRUCTIVE JAUNDICE; RAT; SHORT COURSE THERAPY; SINGLE DRUG DOSE; TREATMENT OUTCOME; WISTAR RAT; ANIMAL; BILE DUCT; BLOOD; CHOLESTASIS; DRUG EFFECT; DRUG POTENTIATION; LIGATION; LIVER; LIVER CELL; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY;

ANIMALS; APOPTOSIS; BILE DUCTS; BILIRUBIN; CHOLESTASIS; CYTOKINES; HEPATOCYTES; INFLAMMATION MEDIATORS; JAUNDICE, OBSTRUCTIVE; LIGATION; LIVER; MALE; MALONDIALDEHYDE; PPAR ALPHA; PROCETOFEN; RATS; RATS, WISTAR;

EID: 38849137817     PISSN: None     EISSN: 1471230X     Source Type: Journal    
DOI: 10.1186/1471-230X-7-44     Document Type: Article

References (31)

1. Trauner M Meierer PJ Boyer JL Molecular pathogenesis of cholestasis New Eng J Med 1998, 39:1217-1227 10.1056/NEJM199810223391707
2. Miyoshi H Rust C Roberts PJ Burgart LJ Gores GJ Hepatocyte apoptosis after bile duct ligation in the mouse involves Fas Gastroenterology 1999, 117:669-677 10.1016/S0016-5085(99)70461-0 10464144
3. Allen RT Hunter WJ 3rd Agrawal DK Morphological and biochemical characterization and analysis of apoptosis J Pharm Toxicol Methods 1997, 37:215-228 10.1016/S1056-8719(97)00033-6
4. Patel T Bronk SF Gores GJ Increases of intracellular magnesium promote glycodeoxycholate-induced apoptosis in rat hepatocytes J Clin Invest 1994, 94:2183-2192 330043 7989573
5. Gonzalez FJ Peters JM Cattley RC Mechanism of action of the nongenotoxic peroxisome proliferators: Role of the peroxisome proliferator-activator receptor alpha J Natl Cancer Inst 1998, 18:1702-1719 10.1093/jnci/ 90.22.1702
6. Zimetbaum P Frishman WH Kahn S Effects of gemfibrozil and other fibric acid derivatives on blood lipids and lipoproteins J Clin Pharmacol 1991, 31:25-37 2045526
7. Le Jossic-Corcos C Duclos S Ramirez LC Zaghini I Chevillard G Martin P Pineau T Bournot P Effects of peroxisome proliferator-activated receptor alpha activation on pathways contributing to cholesterol homeostasis in rat hepatocytes Biochim Biophys Acta 2004, 1683:49-58 15238219
8. Post SM Duez H Gervois PP Staels B Kuipers F Princen HM Fibrates suppress bile acid synthesis via peroxisome proliferator-activated receptor-alpha-mediated downregulation of cholesterol 7alpha-hydroxylase and sterol 27-hydroxylase expression Arterioscler Thromb Vasc Biol 2001, 21:1840-1845 10.1161/hq1101.098228 11701475
9. Stahlberg D Reihner E Rudling M Berglund L Einarsson K Angelin B Influence of bezafibrate on hepatic cholesterol metabolism in gallstone patients: Reduced activity of cholesterol 7 alpha-hydroxylase Hepatology 1995, 21:1025-1030 7705775
10. James NH Soames AR Roberts RA Suppression of hepatocyte apoptosis and induction of DNA synthesis by the rat and mouse hepatocarcinogen diethylhexylphlathate (DEHP) and the mouse hepatocarcinogen 1,4-dichlorobenzene (DCB) Arch Toxicol 1998, 72:784-790 10.1007/ s002040050574 9950075
11. Hasmall SC James NH Macdonald N Gonzalez FJ Peters JM Roberts RA Suppression of mouse hepatocyte apoptosis by peroxisome proliferators: role of PPAR alpha and TNF alpha Mutat Res 2000, 448;:193-200 10725472
12. Gill JH James NH Roberts RA Dive C The non-genotoxic hepatocarcinogen nafenopin suppresses rodent hepatocyte apoptosis induced by TGFbeta1, DNA damage and Fas Carcinogenesis 1998, 19:299-304 10.1093/carcin/ 19.2.299 9498280
13. Gonzalez FJ The peroxisome proliferator-activated receptor alpha (PPARalpha): Role in hepatocarcinogenesis Mol Cell Endocrinol 2002, 193:71-9 10.1016/S0303-7207(02)00098-9 12161004
14. Xiao S Anderson SP Swanson C Bahnemann R Voss KA Stauber AJ Corton JC Activation of peroxisome proliferator-activated receptor alpha enhances apoptosis in the mouse liver Toxicol Sci 2006, 92:368-77 10.1093/toxsci/ kfl002 16687391
15. Montanaro MA Bernasconi AM Gonzalez MS Rimoldi OJ Brenner RR Effects of fenofibrate and insulin on the biosynthesis of unsaturated fatty acids in streptozotocin diabetic rats Prostaglandins Leukot Essent Fatty Acids 2005, 73:369-78 10.1016/j.plefa.2005.06.004 16099631
16. Ohkawa H Ohishi N Yagi K Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction Anal Biochem 1979, 95:351-358 10.1016/ 0003-2697(79)90738-3 36810
17. Knodell RG Ishak KG Black WC Chen TS Craig R Kaplowitz N Kiernan TW Wollman J Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis Hepatology 1981, 1:431-5 10.1002/hep.1840010511 7308988
18. Ishak K Baptista A Bianchi L Callea F De Groote J Gudat F Denk H Desmet V Korb G MacSween RN Histological grading and staging of chronic hepatitis J Hepatol 1995, 22:696-9 10.1016/0168-8278(95)80226-6 7560864
19. Reddy JK Rao MS Peroxisome proliferation and hepatocarcinogenesis IARC Sci Publ 1992, 116:225-235 1428083
20. Frick MH Elo O Haapa K Heinonen OP Heinsalmi P Helo P Huttunen JK Kaitaniemi P Koskinen P Manninen V Helsinki Heart Study: primary-prevention trial with gemfibrozil in middle-aged men with dyslipidemia. Safety of treatment, changes in risk factors, and incidence of coronary heart disease N Engl J Med 1987, 317:1237-1245 3313041
21. Weis HJ Dietschy JM Presence of an intact cholesterol feedback mechanism in the liver in biliary stasis Gastroenterology 1971, 61:77-84 5088529
22. Danielsson H Effect of biliary obstruction on formation and metabolism of bile acids in rat Steroids 1973, 22:567-79 10.1016/ 0039-128X(73)90013-5 4147790
23. Lowe SW Lin AW Apoptosis in cancer Carcinogenesis 2000, 21:485-95 10.1093/carcin/21.3.485 10688869
24. Cosulich SC James NH Needham MR Newham PP Bundell KR Roberts A dominant negative form of IKK2 prevents suppression of apoptosis by the peroxisome proliferator nafenopin Carcinogenesis 2000, 21:1757-60 10.1093/carcin/21.9.1757 10964109
25. Kleemann R Verschuren L de Rooji BJ Lindeman J de Maat MM Szalai AJ Princen HMG Kooistra T Evidence for anti-inflammatory activity of stains and PPARα activators in human C-reactive protein transgenic mice in vivo and in cultured human hepatocytes in vitro Blood 2004, 103:4188-94 10.1182/blood-2003-11-3791 14976045
26. Anderson SP Dunn CS Cattley RC Corton JC Hepatocellular proliferation in response to a peroxisome proliferator does not require TNFalpha signaling Carcinogenesis 2001, 22:1843-51 10.1093/carcin/22.11.1843 11698348
27. Corton JC Fan LQ Brown S Anderson SP Bocos C Cattley RC Mode A Gustafsson JA Down-regulation of cytochrome P450 2C family members and positive acute-phase response gene expression by peroxisome proliferator chemicals Mol Pharmacol 1998, 54:463-473 9730905
28. Toyama T Nakamura H Harano Y Yamauchi N Morita A Kirishima T Minami M Itoh Y Okanoue T PPARalpha ligands activate antioxidant enzymes and suppress hepatic fibrosis in rats Biochem Biophys Res Commun 2004, 324:697-704 10.1016/j.bbrc.2004.09.110 15474484
29. Dohmen K Mizuta T Nakamuta M Shimohashi N Ishibashi H Yamamoto K Fenofibrate for patients with asymptomatic primary biliary cirrhosis World J Gastroenterol 2004, 10:894-898 15040040
30. Ho CY Kuo TH Chen TS Tsay SH Chang FY Lee SD Fenofibrate-induced acute cholestatic hepatitis J Chin Med Assoc 2004, 67:245-247 15357112
31. Ohira H Sato Y Ueno T Sata M Fenofibrate treatment in patients with primary biliary cirrhosis Am J Gastroenterol 2002, 97:2147-2149 10.1111/ j.1572-0241.2002.05944.x 12190200